Ibotta IBTA 深 滬
等待開盤 09-24 09:30:00 美东时间
41.21
+0.570
+1.40%
華盛通- 最 高42.30
- 今 開41.25
- 成交量 26.32万股
- 最 低 40.34
- 昨 收 40.64
- 總市值 9.55亿
- 52周最高 43.43
- 市盈率 靜 346.89
- 換手率 1.14%
- 52周最低 19.10
- 委 比 0.00%
- 總股本 2316.96万
- 歷史最高 117.59
- 量 比 1.31
- 振 幅 4.82%
- 歷史最低 19.10
- 每 手 1
- 風險率 5.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 绩优股齐升！Palantir大涨逾29%，Q2营收强劲增长并上调全年指引；Wayfair飙升30%，Corvex涨逾27%
绩优股齐升！Palantir大涨逾29%，Q2营收暴增93%并上调全年指引；Wayfair飙升30%，Q2业绩全面超预期；Corvex涨逾27%，斩获AI巨头Blackwell供应协议>>
08-05 19:24
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
Ibotta, Inc. Earnings Call Signals Network-Driven Growth
Ibotta, Inc. Class A (($IBTA)) has held its Q2 earnings call. Read on for the m...
08-05 08:28
Caterpillar, Wayfair, Zebra Technologies, Gartner And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 500 points on Tuesday. Shares of Caterpillar Inc (NYSE:CAT) rose sharply during Tuesday’s session after the construction and mining equipment maker reported second-quarter 2026 revenue and raised its full-year sales outlook. Adjusted E...
08-04 22:00
Ibotta shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.
Ibotta shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.
08-04 20:38
Needham Reiterates Buy on Ibotta, Maintains $45 Price Target
Needham analyst Bernie McTernan reiterates Ibotta (NYSE:IBTA) with a Buy and maintains $45 price target.
08-04 19:02
Ibotta Sees Q3 Sales $86.000M-$90.000M vs $83.376M Est
Ibotta (NYSE:IBTA) sees Q3 sales of $86.000 million-$90.000 million vs $83.376 million analyst estimate.
08-04 04:18
美股大行评级 | 潜在涨幅215.37%！摩根士丹利上调TeraWulf(WULF)目标价至72美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从66.5美元升至72美元；HC Wainwright & Co.：维持Vera Therapeutics"买入"评级，目标价从110美元升至125美元
07-09 12:35
Goldman Sachs Maintains Sell on Ibotta, Lowers Price Target to $28
Goldman Sachs analyst Eric Sheridan maintains Ibotta (NYSE:IBTA) with a Sell and lowers the price target from $32 to $28.
07-08 19:01
Ibotta Reports Q1 2026 Results: Full Earnings Call Transcript
Ibotta (NYSE:IBTA) reported first-quarter financial results on Wednesday. The t...
05-28 13:58
